Flagship Harbor Advisors, LLC Crispr Therapeutics Ag Transaction History

Flagship Harbor Advisors, LLC

$1.74 Billion
Q3 2024

A detailed history of Flagship Harbor Advisors, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Flagship Harbor Advisors, LLC holds 6,073 shares of CRSP stock, worth $248,628. This represents 0.02% of its overall portfolio holdings.

Number of Shares

6,073

Previous 6,553 7.32%

Holding current value

$248,628

Previous $446,000 36.1%

% of portfolio

0.02%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$44.62 - $62.75 $21,417 - $30,120	-480 Reduced 7.32%	6,073 $285,000
Q1 2024 Apr 16, 2024	SELL	$60.67 - $89.12 $2,608 - $3,832	-43 Reduced 0.65%	6,553 $446,000
Q4 2023 Jan 10, 2024	BUY	$38.62 - $72.18 $22,167 - $41,431	574 Added 9.53%	6,596 $412,000
Q3 2023 Oct 17, 2023	BUY	$45.39 - $59.0 $9,486 - $12,331	209 Added 3.6%	6,022 $273,000
Q2 2023 Jul 11, 2023	BUY	$43.47 - $67.77 $23,778 - $37,070	547 Added 10.39%	5,813 $326,000
Q1 2023 Apr 12, 2023	BUY	$41.0 - $56.12 $8,200 - $11,224	200 Added 3.95%	5,266 $238,000
Q4 2022 Jan 13, 2023	BUY	$39.19 - $65.67 $1,959 - $3,283	50 Added 1.0%	5,066 $0
Q3 2022 Oct 13, 2022	SELL	$61.1 - $83.78 $2,199 - $3,016	-36 Reduced 0.71%	5,016 $328,000
Q2 2022 Jul 13, 2022	SELL	$43.23 - $73.83 $3,112 - $5,315	-72 Reduced 1.41%	5,052 $307,000
Q1 2022 Apr 13, 2022	BUY	$53.19 - $79.24 $12,393 - $18,462	233 Added 4.76%	5,124 $322,000
Q4 2021 Feb 10, 2022	BUY	$70.09 - $111.29 $19,835 - $31,495	283 Added 6.14%	4,891 $371,000
Q2 2021 Jul 26, 2021	BUY	$100.84 - $161.89 $150,957 - $242,349	1,497 Added 48.12%	4,608 $746,000
Q1 2021 May 03, 2021	BUY	$110.72 - $210.04 $5,093 - $9,661	46 Added 1.5%	3,111 $379,000
Q4 2020 Feb 08, 2021	BUY	$79.67 - $173.23 $4,381 - $9,527	55 Added 1.83%	3,065 $469,000
Q3 2020 Oct 13, 2020	SELL	$78.5 - $100.64 $54,165 - $69,441	-690 Reduced 18.65%	3,010 $251,000
Q2 2020 Jul 31, 2020	BUY	$38.5 - $76.05 $5,775 - $11,407	150 Added 4.23%	3,700 $271,000
Q1 2020 May 12, 2020	BUY	$33.68 - $62.53 $29,739 - $55,213	883 Added 33.11%	3,550 $151,000
Q4 2019 Feb 14, 2020	SELL	$36.68 - $73.13 $1,540 - $3,071	-42 Reduced 1.55%	2,667 $162,000
Q3 2019 Oct 22, 2019	SELL	$40.99 - $52.56 $24,594 - $31,536	-600 Reduced 18.13%	2,709 $111,000
Q1 2019 Apr 15, 2019	BUY	$28.02 - $40.87 $16,812 - $24,522	600 Added 22.15%	3,309 $118,000
Q4 2018 Jan 28, 2019	BUY	$22.73 - $42.34 $55,529 - $103,436	2,443 Added 918.42%	2,709 $77,000
Q3 2018 Nov 05, 2018	SELL	$44.35 - $65.71 $4,435 - $6,570	-100 Reduced 27.32%	266 $11,000
Q2 2018 Aug 14, 2018	BUY	$42.62 - $73.59 $15,598 - $26,933	366 New	366 $21,000

Others Institutions Holding CRSP

# of Institutions

490

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.19B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.

Account

Flagship Harbor Advisors, LLC Crispr Therapeutics Ag Transaction History